• Assay Selection Tool

BellBrook Labs

  • Products
    • Transcreener® HTS Assay Kits
      • Transcreener® ADP² Kinase Assay Kits
        • Transcreener® ADP2 Assay Kit – FP Readout
        • Transcreener® ADP2 Assay Kit – FI Readout
        • Transcreener® ADP2 Assay Kit – TR-FRET Readout
      • Transcreener® ADO CD73 Assay Kit
      • Transcreener® AMP²/GMP² Phosphodiesterase Assay Kits
        • Transcreener® AMP2/GMP2 FP Assay
        • Transcreener® AMP2/GMP2 Assay Kit – TR-FRET Readout
      • Transcreener® cGAMP cGAS Assay Kits
        • Transcreener® cGAMP Assay Kit – FP Readout
        • Transcreener® cGAMP Assay Kit – TR-FRET Readout
      • Transcreener dAMP Exonuclease Assay Kit
      • Transcreener® EPIGEN SAH Methyltransferase Assay Kit
      • Transcreener® GDP GTPase Assay Kits
        • Transcreener® GDP Assay Kit – FP Readout
        • Transcreener® GDP Assay Kit – FI Readout
        • Transcreener® GDP Assay Kit – TR-FRET Readout
      • Transcreener® UDP² Glycosyltransferase Assay Kits
        • Transcreener® UDP2 Assay Kit – FP Readout
        • Transcreener® UDP2 Assay Kit – FI Readout
        • Transcreener® UDP2 Assay Kit – TR-FRET Readout
      • Transcreener® 2-5A OAS Assay Kit
    • AptaFluor® HTS Assay Kits
      • AptaFluor® SAH Methyltransferase Assay Kit
    • Enzyme Assay Systems
      • TREX1 Assay System
    • Recombinant Enzymes
      • Human cGAS Enzyme
      • Mouse cGAS Enzyme
      • Human DDX3 Enzyme
      • Human OAS1 Enzyme
      • Human TREX1 Enzyme
    • Assay Plates
    • Ordering Information
  • Services
    • Assay Development Services
    • Lead Discovery Services
    • CD38 Assay Services
    • GTPase Profiling Services
    • ATPase Profiling Services
  • Assays by Target
    • Kinase Assays
      • ADK Assays – Application
      • AMPK Assays – Application
      • IKK-beta Assays – Application
      • IRAK4 Assays – Application
      • JAK1 Assays – Application
      • JAK3 Assays – Application
      • MAPK8 Assays – Application
      • PKR Assays – Application
      • RIPK1 Assays – Application
      • RIPK2 Assays – Application
      • TBK1 Assays – Application
    • GTPase Assays
      • GAP Assays – Application
      • GEF Assays – Application
      • KRAS Assays – Application
      • HRAS Assays – Application
      • NRAS Assays – Application
      • RRAS Assays – Application
      • Rac1 Assays – Application
      • RhoA Assays – Application
      • RhoC Assays – Application
      • Cdc42 Assays – Application
      • Ran Assays – Application
    • Methyltransferase Assays
      • EZH2 Assays – Application
      • G9a Assays – Application
      • SET7/9 Assays – Application
      • SET8 Assays – Application
      • PRMT1 Assays – Application
      • PRMT3 Assays – Application
      • PRMT4 Assay – Application
    • STING Pathway Assays
      • cGAS Assay Kits
      • ENPP1 Assays – Application
      • TREX1 Assay System
      • IKK-beta Assays – Application
      • TBK1 Assays – Application
    • Nucleotidase Assays
      • CD38 Assay Services
      • CD39 Assays – Application
      • CD73 Activity Assay Kits
    • Helicase / ATPase Assays
      • DDX3 Assays – Application
      • NSP13 Assays – Application
      • P97 Assays – Application
    • Glycosyltransferase Assays
      • Toxin B Assays – Application
      • GALNT2 Assays – Application
      • GALNT3 Assays – Application
      • BGalT1 Assays – Application
    • Phosphodiesterase Assays
      • PDE3 Assays – Application
      • PDE4 Assays – Application
      • PDE5 Assays – Application
      • PDE7 Assays – Application
    • Ligase and Synthetase Assays
      • SUMO E1 Assays – Application
      • Acyl CoA Synthetase Assays – Application
      • S-Acetyl CoA Synthetase Assays – Application
    • Exonuclease Assays
      • TREX1 Assay System
    • OAS Assays
      • OAS1 Assay Kits
    • Other Enzyme Assays
      • NUDT5 Assays – Application
  • Resources
    • Technical Manuals
    • Transcreener® Assays – Instrument Compatibility
    • Application Notes
    • Posters and Presentations
    • Publications
    • Transcreener® FAQ’s
    • Guides
      • Residence Time Guide
      • Hit Prioritization Guide
      • Kinases in Innate Immunity
  • Company
    • President’s Message
    • International Distributors
    • Careers
    • Downloads
    • Contact Us
  • Blog
  • MY CART
    No products in cart.

How a Methyltransferase Activity Assay Could Help Identify Novel Breast Cancer Treatments

by Bellbrook Labs / Monday, 22 April 2019 / Published in HTS Assays, Products
Pink Stethascope DOT1L Breast Cancer Target 420 X 280

As estrogen receptor (ER) positive breast cancer (BC) becomes resistant to antiestrogen therapy, novel ways to control the disease are and continue to be developed. There are different types of breast cancer, and the most effective treatment depends on knowing this difference.  For example, if the type is estrogen receptor positive (ER) meaning cells are relying on this protein receptor to grow, then a therapy blocking the receptor is imperative.1 What happens when these types of cancer cells become resistant to the so-called antiestrogen therapies, which often occurs? Even though there is a myriad of potential causes for resistance, the bottom line is that it must be stopped or at the very least, controlled in order for patients to remain living cancer free. A recent study found a histone methyltransferase called DOT1L (disruptor of telomeric silencing-1-like) that when inhibited, silences the ERα gene making it a potential target for treating antiestrogen resistant ER-positive BCs.²

Histone methyltransferases (HMT) are enzymes that assist in the transferring of methyl groups to lysine and arginine residues of histone proteins. Histone methylation plays an essential role in a variety of biological processes such as gene expression, cell lineage development, and mitosis. Nassa et al. found that both the H3K79 methyltransferase, DOT1L, and the ERα protein associate together with chromatin.3 In addition, after further investigation of the chromatin-bound ERα-DOT1L complex, they observed other molecules involved in the progression of ER-positive BCs via cell cycle progression, cell survival, and transcription.  Moreover, they found that when DOT1L was inhibited, a decreased progression in ER-positive BCs was detected.

Being able to measure HMTs activity is necessary especially in research involving gene regulation. DOT1L, as well as other HMTs, can be calculated using a methyltransferase activity assay.

How Can a Methyltransferase Activity Assay Help?

While most methyltransferase activity assays detect the invariant product of HMT reactions, S-adenosylhomocysteine (SAH) indirectly or by the use of coupled enzymes, the AptaFluor SAH Methyltransferase Assay affords direct detection. Not only is this universal approach capable of detecting a range of HMT activity including DOT1L, it also allows for more sensitive binding to SAH making the assay remarkable for high-throughput screening (HTS).4   Whether researching gene regulation in breast cancer or exploring DNA repair mechanisms, the AptaFluor SAH Methyltransferase Assay can assist in evaluating the HMT of interest, finding new inhibitors faster, thus accelerating drug discovery.

DOT1L Titration Using Methyltransferase Activity AssayDOT1L Titration Under Initial Velocity ConditionsInhibitor Potency with DOT1L

A. Dot1L was titrated in the presence of 200 nM SAM and 10 ng/µL of mono/di nucleosomes to determine an optimal EC80 concentration of 6 ng/µL. Reactions were incubated at 30C for two hours. B. TR-FRET values were converted to SAH production to assess reaction progress. C. Dose-response curves with two known inhibitors of Dot1L, EPZ004777 and EPZ5676 show an IC50 value of 1.7 nM and 1.4 nM respectively.

References

  1. Cancer B, Breast Cancer Hormone Receptor Status 2019:1-4. https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-hormone-receptor-status.html
  2. Frogne T, Jepsen JS, Larsen SS, Fog CK, Brockdorff BL, Lykkesfeldt AE. Antiestrogen-resistant human breast cancer cells require activated Protein Kinase B / Akt for growth. 2005:599-614. https://europepmc.org/abstract/med/16172194
  3. Nassa G, Salvati A, Tarallo R, et al. Inhibition of histone methyltransferase DOT1L silences ERα gene and blocks proliferation of antiestrogen-resistant breast cancer cells. 2019;(February):1-15. https://advances.sciencemag.org/content/5/2/eaav5590
  4. AptaFluor SAH: A Homogenous, Universal Methyltransferase Assay Based on a Microbial Riboswitch Meera Kumar and Robert G . Lowery. :2017. https://www.bellbrooklabs.com/wp-content/uploads/2018/01/AptaFluor-SAH-A-Homogenous-Universal-Methyltransferase-Assay-Based-on-a-Microbial-Riboswitch-DOT-2017.pdf
Tagged under: AptaFluor SAH Methyltransferase Assay, methyltransferase

What you can read next

Inhibitors of ENPP1 SLAS Discovery
New Publication by the Scientists at BellBrook Labs – Development of a High-Throughput Assay to Identify Inhibitors of ENPP1
Scientist Studying DDX41
DDX41 as a Sensor, Suppressor, and Modulator
Scientist Working on CD38 Discovery
The Role of CD38 Activity in the Impaired Immune Response

Categories

  • Company
  • Emerging Targets
  • Epigenetics
  • HTS Assays
  • Innate Immunity
  • Neurodegenerative Diseases
  • News
  • Products
  • Resources
  • Success Stories
  • Uncategorized

Recent Posts

  • PARP1 as a Hero vs Villain

    Is PARP1 a Hero or Villain?

    Not counting histones, PARP1 [Poly(ADP-ribose) ...
  • Ongoing Puzzle of c-SRC in Cancer Treatment

    Advancements in The Ongoing Puzzle to Understand c-SRC

    Nearly a half-century ago, sequences from the R...
  • SLAS 2023 Conference Exhibitor Announcement

    SLAS 2023 – HTS Assays and Discovery Services

    BellBrook Labs will exhibit and present posters...
  • BTK's Involved in Systemic lupus erythematosus

    The Challenging Search for BTK Inhibitors

    Bruton’s Tyrosine Kinase (BTK) is a 76kDa...
  • SARM1 Causes Axonal Death

    SARM1 Forefronts Research into Major Neurological Diseases

    SARM1 [Sterile alpha & toll/interleukin rec...

Archives

BellBrook Labs
5500 Nobel Drive, Suite 230
Madison, Wisconsin 53711 USA
(608) 443-2400

info@bellbrooklabs.com

 Copyright © 2023 BellBrook Labs | All Rights Reserved | Privacy Policy | Terms of Use | FCOI | Sitemap

TOP